PARP inhibitors for hereditary breast cancer with germline BRCA mutation

被引：0
|
作者：
Im, Seock-Ah [1 ]
机构：
[1] Seoul Natl Univ, Canc Res Inst, Dept Internal Med, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.426
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PSY8-3
引用
收藏
页码：S423 / S423
页数：1
相关论文
共 50 条
  • [21] Updates on Management of Hereditary Breast Cancer: New Data on PARP Inhibitors Change Recommendations Regarding the Multidisciplinary Care of Breast Cancer Patients with BRCA Mutations
    McGuire, Kandace P.
    Arthur, Douglas W.
    Mamounas, Eleftherios P.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (11) : 6504 - 6507
  • [22] A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer
    de Souza Timoteo, Ana Rafaela
    Menezes Magalhaes Goncalves, Ana Elida
    Porpino Sales, Lucas Amadeus
    Albuquerque, Betina Menezes
    Santana de Souza, Jorge Estefano
    Pascoto de Moura, Patricia Cristina
    Arruda de Aquino, Marcos Alberto
    Agnez-Lima, Lucymara Fassarela
    Petta Lajus, Tirzah Braz
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (03) : 637 - 646
  • [23] A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer
    Ana Rafaela de Souza Timoteo
    Ana Élida Menezes Magalhães Gonçalves
    Lucas Amadeus Porpino Sales
    Betina Menezes Albuquerque
    Jorge Estefano Santana de Souza
    Patrícia Cristina Pascoto de Moura
    Marcos Alberto Arruda de Aquino
    Lucymara Fassarela Agnez-Lima
    Tirzah Braz Petta Lajus
    Breast Cancer Research and Treatment, 2018, 172 : 637 - 646
  • [24] Pathologic findings at RRSO in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
    Lee, YoungJae
    Kim, YongMan
    Lee, ShinWha
    CANCER RESEARCH, 2017, 77
  • [25] Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report
    Ying Liu
    Jing Zhu
    Xiao Wei
    Duoxia Yang
    Si Li
    Xiaoping Qian
    Li Li
    Journal of Ovarian Research, 15
  • [26] Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline BRCA1 mutation: a case report
    Liu, Ying
    Zhu, Jing
    Wei, Xiao
    Yang, Duoxia
    Li, Si
    Qian, Xiaoping
    Li, Li
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [27] PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?
    Frizzell, Kristine M.
    Kraus, W. Lee
    BREAST CANCER RESEARCH, 2009, 11 (06):
  • [28] PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?
    Kristine M Frizzell
    W Lee Kraus
    Breast Cancer Research, 11
  • [29] Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers
    Shafaee, Maryam Nemati
    Goutsouliak, Kristina
    Lin, Heather
    Bevers, Therese B.
    Gutierrez-Barrera, Angelica
    Bondy, Melissa
    Arun, Banu
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (01) : 143 - 152
  • [30] Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers
    Maryam Nemati Shafaee
    Kristina Goutsouliak
    Heather Lin
    Therese B. Bevers
    Angelica Gutierrez-Barrera
    Melissa Bondy
    Banu Arun
    Breast Cancer Research and Treatment, 2022, 196 : 143 - 152
12345